declares having received consulting honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer, and research grants from British Heart Foundation, MRC (UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate and Roche
So your takeaway is the evidence leans in your favor, but how much depends on what youd otherwise be taking. Worth a real conversation with whoever manages your diabetes, not a reason to panic or to celebrate
The mechanism of action does not directly involve the coagulation cascade or platelet function, which has led to questions about whether these medications might influence thrombotic risk
Even though Ozempic, Mounjaro and Wegovy are off the shortages list, pharmacies have reported difficulty obtaining enough of these drugs to meet demand, Davis says